Amneal, Impax combine to creates diversified pharma company Ruby Khatun Khatun26 Oct 2017 9:05 AM ISTBRIDGEWATER, New Jersey and HAYWARD, California: Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. announced that they have entered into a...
AbbVie bets on Alzheimers immunotherapy with big biotech deal Ruby Khatun Khatun26 Oct 2017 9:00 AM ISTU.S. drugmaker AbbVie is betting on the potential of the body’s immune system to fight Alzheimer’s by signing a drug development deal worth more than...
Panacea Biotec gets USFDA nod to launch Prasugrel tablets Ruby Khatun Khatun25 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Panacea Biotec said it has received final approval from the US health regulator to launch generic Prasugrel tablets, used for...
Lupin gets FDA approval for drug to treat Parkinson disease Ruby Khatun Khatun25 Oct 2017 10:12 AM ISTMUMBAI: Pharma major Lupin on Tuesday said it has received final approval for its carbidopa tablets, used for treatment of idiopathic Parkinson's...
AstraZeneca gets FDA approval for BYDUREON BCise Injectable medicine for Type-2 Diabetes Ruby Khatun Khatun25 Oct 2017 9:47 AM ISTWILMINGTON, Del.: AstraZeneca announced that the US Food and Drug Administration (FDA) has approved BYDUREON® BCise™ (exenatide extended-release)...
Fleming Labs Nawabpet facility comes under USFDA scanner Ruby Khatun Khatun24 Oct 2017 11:00 AM ISTNew Delhi: The US health regulator has issued an import alert for the drugs and drug products manufactured by Hyderabad-based Fleming Laboratories at...
GSK wins US shingles vaccine approval, UK nod for gene therapy Ruby Khatun Khatun24 Oct 2017 10:30 AM ISTLONDON: GlaxoSmithKline (GSK) has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British...
Novartis gets FDA breakthrough status for Tafinlar, Mekinist combination Ruby Khatun Khatun24 Oct 2017 10:00 AM ISTZURICH: Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and...
AstraZeneca among backers as Swiss cancer biotech raises 200 million dollars Ruby Khatun Khatun24 Oct 2017 9:30 AM ISTLONDON: An unlisted Swiss biotech company focused on developing “armed antibodies” to fight cancer has raised $200 million in a funding round backed...
ICMR proposes Suspension of Commercial Stem Cell Banking, Industry Reacts Ruby Khatun Khatun24 Oct 2017 9:09 AM ISTThe Indian Council of Medical Research (ICMR) had made recommendations in its National guidelines to stem cell research, 2017, to suspend commercial...
Now non-essential drugs fall under price control Ruby Khatun Khatun23 Oct 2017 5:45 PM ISTNew Delhi: The government's push for a change in the method of price calculation methodology for new drugs can lead to non-essential drugs coming...
Merck cyber attack may cost insurers 275 million dollars: Verisks PCS Ruby Khatun Khatun23 Oct 2017 9:57 AM ISTNEW YORK: Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a...
